EASD 2021: Osteoporosis drug appears to lower diabetes risk
Treatment with alendronate, an osteoporosis drug, appears to reduce the risk of developing type 2 diabetes, researchers reported on Sept. 26, 2021 at the annual meeting of the […]
Treatment with alendronate, an osteoporosis drug, appears to reduce the risk of developing type 2 diabetes, researchers reported on Sept. 26, 2021 at the annual meeting of the […]
Chronic back pain affects upwards of 15 million adults in the US, racking up billions in healthcare costs and lost work days. Degeneration of the discs that cushion […]
New research carried out under the auspices of the Canadian Multicentre Osteoporosis Study (CaMos) has found that cognitive decline is linked with accelerated bone loss and an increased […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
